Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
33.25    -0.60 (-1.77%)
Bid:
32.75
Ask:
33.20
Spread: 0.45 (1.374%)
Market Cap: £221.40m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Fourth Quarter Trading Update

26 Jan 2026 07:00

RNS Number : 2546Q
S4 Capital PLC
26 January 2026
 

S4 Capital PLC

26 January 2026

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 on market abuse ("UK MAR"), as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. 

 

 

S4 Capital plc

Fourth Quarter Trading Update

("S4 Capital", "the Company" or "the Group")

 

2025 full year ahead of revised guidance and current consensus

Liquidity and net debt significantly improved and leverage expected to be 1.1x operational EBITDA

Final dividend of 1p subject to Board and Shareowner approval

 

 

S4 Capital plc (SFOR.L) confirms that 2025 full year trading was ahead of the revised guidance issued on the 24 November 2025 and is above the current consensus of net revenue of £664 million and operational EBITDA of £75 million. The Company expects like-for-like net revenue to be down circa 8.5%, with an operational EBITDA margin of circa 12%.

 

Net debt will be both significantly below current consensus of £133 million and below the previously indicated range of £100-140 million, following a change in Treasury management and a consequent strong focus on working capital management resulting in an improvement in liquidity.

 

The net debt to operational EBITDA ratio at the end of 2025 is expected to be approximately 1.1x versus current consensus of 1.8x and well below the target of 1.5x.

 

The annual results for 2025 will be announced on 25 March 2026 at which point the Company will provide more detailed targets for 2026.

 

The Company will recommend a 1p dividend, subject to the finalisation of the annual results and approval from the Board and Shareowners.

 

 

Sir Martin Sorrell, Executive Chairman of S4Capital plc said:

 

"Good to see both delivery beyond revised net revenue and operational EBITDA guidance and the significant improvement in liquidity. However, there is still much more to be done around net revenue and margin growth in 2026 and beyond which we will cover with the 2025 results presentation in March. The recommended 1p final dividend is an indication of the Board's confidence in continued improvement. In an increasingly volatile world, clients continue to carefully assess where they should expand geographically and how they can apply new technologies such as AI, Blockchain and Quantum to increasing efficiency."

 

 

Enquiries to:

S4Capital plc

+44 (0)20 3793 0003

Sir Martin Sorrell (Executive Chairman)

 

 

About S4Capital

 

Our strategy is to build a purely digital advertising and marketing services business for global, multinational, regional, and local clients, and millennial-driven influencer brands. We now have two synchronised practices: Marketing services and Technology services, along with an emphasis on 'faster, better, cheaper, more' execution in an always-on consumer-led environment, with a unitary structure.

The Company now has approximately 6,300 people in 33 countries with approximately 80% of net revenue across the Americas, 15% across Europe, the Middle East and Africa and 5% across Asia-Pacific. The longer-term objective is a geographic split of 60%:20%:20%.

 

Sir Martin was CEO of WPP for 33 years, building it from a £1 million 'shell' company in 1985 into the world's largest advertising and marketing services company, with a market capitalisation of over £16 billion on the day he left. Prior to that Sir Martin was Group Financial Director of Saatchi & Saatchi Company Plc for nine years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEIFWIEMSELF
Date   Source Headline
19th Sep 20247:00 amRNSInterim Results for 2024
2nd Sep 20243:45 pmRNSTotal Voting Rights
14th Aug 20247:00 amRNSNotice of Interim Results
1st Aug 20249:31 amRNSTotal Voting Rights
1st Aug 20249:30 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSIssue of Shares
24th Jul 202411:23 amRNSDirector/PDMR Shareholding
2nd Jul 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:30 amRNSTotal Voting Rights
28th Jun 20247:00 amRNSIssue of Equity
14th Jun 20243:02 pmRNSDirector/PDMR Shareholding
14th Jun 20247:00 amRNSIssue of Shares
6th Jun 20243:51 pmRNSResult of AGM
6th Jun 202412:00 pmRNSAGM Statement
3rd Jun 20249:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSIssue of Shares
10th May 20247:00 amRNSFirst Quarter Trading Update
9th May 202410:01 amRNSNotice of AGM
9th May 20247:00 amRNSIssue of Shares
3rd May 20249:00 amRNSIssue of Shares
30th Apr 202411:25 amRNSNotice of Q1 Trading Update
29th Apr 20247:00 amRNSBoard Change
3rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSAudited 2023 preliminary results
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSNotice of Results
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSIssue of Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.